Literature DB >> 27625583

Clinical presentation and treatment outcome of molar pregnancy: Ten years experience at a Tertiary Care Hospital in Dammam, Saudi Arabia.

Ayman A Al-Talib1.   

Abstract

OBJECTIVES: To study the clinical presentation and treatment outcome of molar pregnancy at a Tertiary Care Hospital in Dammam, Saudi Arabia.
MATERIALS AND METHODS: Reviewed medical records of all molar pregnancy cases among all the deliveries at a tertiary care hospital in Dammam from 2005 to 2014, after approval by institutional ethical review committee. Data abstracted included patient's age, parity, presenting symptoms, gestational age at diagnosis, uterine size, ultrasonographic findings, BhCG level at the time of diagnosis and at follow-up after evacuation, and blood loss during evacuation. Data was entered and analyzed using Excel; frequency distribution for categorical variables and descriptive statistics for continuous variables were computed.
RESULTS: Of a total of 25,000 deliveries in ten years, 22 cases of complete molar pregnancy were encountered: 0.9 cases of molar pregnancy per 1000 pregnancies. Majority of patients (63.7%) were older than 35 years, and were nulliparous (45.5%). The commonest symptom was vaginal bleeding (86.4%) followed by hyperemesis gravidarum (41.0%); Hyperthyroidism was seen in 1 patient (4.5%). Ovarian enlargement by theca-lutin cyst was seen in 3 patients (13.6%). The majority of patients (63.6%) had normal BhCG within 9 weeks (63 days) after suction curettage. The majority of the cases followed a benign course.
CONCLUSION: Aged older than 35 years seems a risk factor and vaginal bleeding is the commonest presenting symptom. Early booking of pregnant women to antenatal care clinics and routine first trimester ultrasound made diagnosis easier and earlier before complications appear.

Entities:  

Keywords:  Complete mole; GTD; Saudi Arabia; hydatidform mole; molar pregnancy

Year:  2016        PMID: 27625583      PMCID: PMC5009886          DOI: 10.4103/2230-8229.189129

Source DB:  PubMed          Journal:  J Family Community Med        ISSN: 1319-1683


  23 in total

Review 1.  Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases.

Authors:  Robert A Waterland; Randy L Jirtle
Journal:  Nutrition       Date:  2004-01       Impact factor: 4.008

2.  Placental Molar Disease: What are the Benefits and Barriers to the Adoption of a Comprehensive Diagnostic Service?

Authors:  Elena Kolomietz; Georges Maire; Shabin Nanji; Martin C Chang; Matthew Vlasschaert; Jason Dodge; Terence J Colgan
Journal:  Int J Gynecol Pathol       Date:  2015-09       Impact factor: 2.762

3.  The relationship of maternal age to molar pregnancy incidence, risks for chemotherapy and subsequent pregnancy outcome.

Authors:  P M Savage; A Sita-Lumsden; S Dickson; R Iyer; J Everard; R Coleman; R A Fisher; D Short; S Casalboni; K Catalano; M J Seckl
Journal:  J Obstet Gynaecol       Date:  2013-05       Impact factor: 1.246

4.  Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.

Authors:  Mahmood Bakhtiyari; Masoumeh Mirzamoradi; Parichehr Kimyaiee; Abbas Aghaie; Mohammd Ali Mansournia; Sepideh Ashrafi-Vand; Fatemeh Sadat Sarfjoo
Journal:  Fertil Steril       Date:  2015-06-19       Impact factor: 7.329

5.  Epidemiologic study of gestational trophoblastic diseases in Saudi Arabia.

Authors:  S K Chattopadhyay; B S Sengupta; M al-Ghreimil; Y B Edrees; A Lambourne
Journal:  Surg Gynecol Obstet       Date:  1988-11

Review 6.  Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease.

Authors:  Mary E Gaffield; Nathalie Kapp; Kathryn M Curtis
Journal:  Contraception       Date:  2009-06-04       Impact factor: 3.375

7.  Current clinical features of complete and partial hydatidiform mole in Sweden.

Authors:  Ulrika Joneborg; Lena Marions
Journal:  J Reprod Med       Date:  2014 Jan-Feb       Impact factor: 0.142

8.  Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.

Authors:  A Braga; I Maestá; D Short; P Savage; R Harvey; M J Seckl
Journal:  BJOG       Date:  2015-10-07       Impact factor: 6.531

9.  Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy.

Authors:  N J Sebire; R A Fisher; M Foskett; H Rees; M J Seckl; E S Newlands
Journal:  BJOG       Date:  2003-01       Impact factor: 6.531

10.  Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study.

Authors:  Y K Eysbouts; J Bulten; P B Ottevanger; C M G Thomas; M J Ten Kate-Booij; A E van Herwaarden; A G Siebers; F C G J Sweep; L F A G Massuger
Journal:  Gynecol Oncol       Date:  2015-11-14       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.